CHA News

FDA Authorizes Pediatric COVID-19 Vaccines, CDC Advisers Meet this Week 

For CEOs, CMOs, CNOs, COOs, and infection prevention, quality & patient safety, employee safety staff

The U.S. Food and Drug Administration (FDA) has authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 through 11.  

The Pfizer-BioNTech COVID-19 vaccine for children in this age group is administered as a two-dose primary series, three weeks apart, but is a lower dose (10 micrograms) than that used for ages 12 older (30 micrograms).  

The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices will meet on Nov. 2 to provide recommendations on the pediatric COVID-19 vaccine, prior to formal authorization by the CDC director.